500 related articles for article (PubMed ID: 1684411)
1. Involvement of supraspinal and spinal segmental alpha-2-adrenergic mechanisms in the medetomidine-induced antinociception.
Pertovaara A; Kauppila T; Jyväsjärvi E; Kalso E
Neuroscience; 1991; 44(3):705-14. PubMed ID: 1684411
[TBL] [Abstract][Full Text] [Related]
2. Antinociception induced by alpha-2-adrenoceptor agonists, with special emphasis on medetomidine studies.
Pertovaara A
Prog Neurobiol; 1993 Jun; 40(6):691-709. PubMed ID: 8097888
[TBL] [Abstract][Full Text] [Related]
3. The antinociceptive action of an alpha 2-adrenoceptor agonist in the spinal dorsal horn is due to a direct spinal action and not to activation of descending inhibition.
Hämäläinen MM; Pertovaara A
Brain Res Bull; 1995; 37(6):581-7. PubMed ID: 7670881
[TBL] [Abstract][Full Text] [Related]
4. The role of alpha 2-adrenoceptors of the medullary lateral reticular nucleus in spinal antinociception in rats.
Mansikka H; Pertovaara A
Brain Res Bull; 1995; 37(6):633-8. PubMed ID: 7670889
[TBL] [Abstract][Full Text] [Related]
5. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
Pertovaara A; Bravo R; Herdegen T
Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
[TBL] [Abstract][Full Text] [Related]
6. Spinal potentiation and supraspinal additivity in the antinociceptive interaction between systemically administered alpha 2-adrenoceptor agonist and cocaine in the rat.
Pertovaara A; Hämäläinen MM
Anesth Analg; 1994 Aug; 79(2):261-6. PubMed ID: 7639361
[TBL] [Abstract][Full Text] [Related]
7. The rostroventromedial medulla is not involved in alpha 2-adrenoceptor-mediated antinociception in the rat.
Hämäläinen MM; Pertovaara A
Neuropharmacology; 1993 Dec; 32(12):1411-8. PubMed ID: 8152531
[TBL] [Abstract][Full Text] [Related]
8. Antinociception in bulboreticular neurons of the rat produced by spinally administered medetomidine, an alpha 2-adrenoceptor agonist.
Pertovaara A
Eur J Pharmacol; 1991 Oct; 204(1):9-14. PubMed ID: 1687126
[TBL] [Abstract][Full Text] [Related]
9. Different roles of alpha 2-adrenoceptors of the medulla versus the spinal cord in modulation of mustard oil-induced central hyperalgesia in rats.
Mansikka H; Idänpään-Heikkilä JJ; Pertovaara A
Eur J Pharmacol; 1996 Feb; 297(1-2):19-26. PubMed ID: 8851161
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine injection into the locus ceruleus produces antinociception.
Guo TZ; Jiang JY; Buttermann AE; Maze M
Anesthesiology; 1996 Apr; 84(4):873-81. PubMed ID: 8638842
[TBL] [Abstract][Full Text] [Related]
11. Influence of selective alpha 2-adrenergic agents on mustard oil-induced central hyperalgesia in rats.
Mansikka H; Pertovaara A
Eur J Pharmacol; 1995 Jul; 281(1):43-8. PubMed ID: 8566115
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of the alpha 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats.
Pertovaara A; Hämäläinen MM; Kauppila T; Mecke E; Carlson S
Pain; 1994 May; 57(2):207-215. PubMed ID: 7916451
[TBL] [Abstract][Full Text] [Related]
13. The effect of medetomidine, an alpha 2-adrenoceptor agonist, in various pain tests.
Pertovaara A; Kauppila T; Tukeva T
Eur J Pharmacol; 1990 Apr; 179(3):323-8. PubMed ID: 1973106
[TBL] [Abstract][Full Text] [Related]
14. The effect of a selective alpha2-adrenoceptor antagonist on pain behavior of the rat varies, depending on experimental parameters.
Kauppila T; Jyväsjärvi E; Hämäläinen MM; Pertovaara A
Pharmacol Biochem Behav; 1998 Feb; 59(2):477-85. PubMed ID: 9476998
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ascending nociceptive signals to the rostroventromedial medulla induced by a novel alpha2-adrenoceptor agonist, MPV-2426, following intrathecal application in neuropathic rats.
Pertovaara A; Wei H
Anesthesiology; 2000 Apr; 92(4):1082-92. PubMed ID: 10754629
[TBL] [Abstract][Full Text] [Related]
16. Peripherally administered alpha2-adrenoceptor agonist in the modulation of chronic allodynia induced by spinal nerve ligation in the rat.
Wei H; Pertovaara A
Anesth Analg; 1997 Nov; 85(5):1122-7. PubMed ID: 9356112
[TBL] [Abstract][Full Text] [Related]
17. Spinal antinociception by dexmedetomidine, a highly selective alpha 2-adrenergic agonist.
Kalso EA; Pöyhiä R; Rosenberg PH
Pharmacol Toxicol; 1991 Feb; 68(2):140-3. PubMed ID: 1677190
[TBL] [Abstract][Full Text] [Related]
18. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive actions of dexmedetomidine on dorsal horn neuronal responses in the anaesthetized rat.
Sullivan AF; Kalso EA; McQuay HJ; Dickenson AH
Eur J Pharmacol; 1992 Apr; 215(1):127-33. PubMed ID: 1355441
[TBL] [Abstract][Full Text] [Related]
20. The effects of medetomidine, an alpha-2-adrenoceptor agonist, and cocaine on the tooth pulp-evoked jaw-opening reflex in cat.
Pertovaara A; Kemppainen P; Kauppila T
Pharmacol Biochem Behav; 1991 Feb; 38(2):287-92. PubMed ID: 1676169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
